Related Experiment Video
Updated: Sep 11, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
Historical Perspective of Landmark Trials in Head and Neck Cancers
Ameya A Asarkar1, M Boyd Gillespie2, Cherie-Ann O Nathan1
1Department of Otolaryngology/Head and Neck Surgery, Ochsner-LSU Health, Shreveport, Louisiana, USA.
Objective:
Understanding the historical perspective, including the evolution, conceptualization, and the issues in implementation of clinical trials, is crucial in developing future clinical trials.
Data Sources:
A literature search included the following databases: MEDLINE; Embase; Cochrane Central Register of Controlled Trials; and ClinicalTrials.gov for clinical trials on head and neck cancer.
Review Methods:
Six principal investigators/senior authors of major landmark trials in head and neck cancers conducted over the past 30 years were interviewed. The goal was to get their insight on factors including conceptualization, writing, conducting, and reporting a clinical trial.
Results:
Several roadblocks were identified during our interviews and review of relevant literature. These included methodological and ethical dilemmas of surgical trials, standardization of surgical interventions, lack of exposure to clinical epidemiology for surgeons, and issues with the logistics of conducting clinical trials outside a comprehensive cancer center or an academic medical center. The interviewees and literature review provided insight into how these issues could be mitigated. The strategies included standardized surgical credentialing to provide quality assurance and expertise-based surgical trials, involvement of surgeons early in clinical trials, and collaboration with medical oncology colleagues, decentralization of clinical trials, and a private-public partnership to increase clinical trial enrollment.
Conclusion:
Insight from investigators who have spearheaded landmark clinical trials gave us the opportunity to apply their experience with possible regulatory challenges to methodological issues and to consider practical considerations while conducting clinical trials.
More Related Videos
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview